ISUN INC (ISUN)

US4652461066 - Common Stock

0.1301  0 (-1.51%)

After market: 0.1187 -0.01 (-8.76%)

Fundamental Rating

2

Overall ISUN gets a fundamental rating of 2 out of 10. We evaluated ISUN against 43 industry peers in the Construction & Engineering industry. ISUN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ISUN is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

ISUN had negative earnings in the past year.
ISUN had a negative operating cash flow in the past year.
In the past 5 years ISUN reported 4 times negative net income.
In the past 5 years ISUN reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -29.11%, ISUN is not doing good in the industry: 93.02% of the companies in the same industry are doing better.
ISUN has a worse Return On Equity (-148.01%) than 83.72% of its industry peers.
Industry RankSector Rank
ROA -29.11%
ROE -148.01%
ROIC N/A
ROA(3y)-38.29%
ROA(5y)-21.04%
ROE(3y)-145.73%
ROE(5y)-77.65%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ISUN's Gross Margin of 18.73% is fine compared to the rest of the industry. ISUN outperforms 62.79% of its industry peers.
In the last couple of years the Gross Margin of ISUN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ISUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.98%
GM growth 5Y-1.05%

1

2. Health

2.1 Basic Checks

ISUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ISUN has been increased compared to 1 year ago.
ISUN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ISUN has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.55, we must say that ISUN is in the distress zone and has some risk of bankruptcy.
ISUN's Altman-Z score of -0.55 is on the low side compared to the rest of the industry. ISUN is outperformed by 95.35% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that ISUN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.61, ISUN is in line with its industry, outperforming 53.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACC12.26%

2.3 Liquidity

A Current Ratio of 0.89 indicates that ISUN may have some problems paying its short term obligations.
ISUN has a worse Current ratio (0.89) than 83.72% of its industry peers.
A Quick Ratio of 0.85 indicates that ISUN may have some problems paying its short term obligations.
ISUN's Quick ratio of 0.85 is on the low side compared to the rest of the industry. ISUN is outperformed by 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.85

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.95% over the past year.
ISUN shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.15%.
The Revenue has been growing by 43.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)25.15%
Revenue growth 3Y65.65%
Revenue growth 5Y43.07%
Sales Q2Q%-1.74%

3.2 Future

Based on estimates for the next years, ISUN will show a very strong growth in Earnings Per Share. The EPS will grow by 20.21% on average per year.
ISUN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.80% yearly.
EPS Next Y59.2%
EPS Next 2Y31.71%
EPS Next 3Y30.94%
EPS Next 5Y20.21%
Revenue Next Year2.02%
Revenue Next 2Y7.54%
Revenue Next 3Y17.62%
Revenue Next 5Y15.8%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

ISUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ISUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ISUN's earnings are expected to grow with 30.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.71%
EPS Next 3Y30.94%

0

5. Dividend

5.1 Amount

No dividends for ISUN!.
Industry RankSector Rank
Dividend Yield N/A

ISUN INC

NASDAQ:ISUN (5/22/2024, 8:23:14 PM)

After market: 0.1187 -0.01 (-8.76%)

0.1301

0 (-1.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.11%
ROE -148.01%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.73%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.89
Quick Ratio 0.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)54.95%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y59.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.15%
Revenue growth 3Y65.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y